Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

October 01, 2006 (Vol. 26, No. 17)

CMOs Aim to Boost Production Efficiency

Capacity, Compliance, and Quality Remain the Keystones for Success in Biomanufacturing Operations

  • Laureate Pharma (www.laureatepharma.com)recently signed an agreement with LPath (www.lpath.com) to manufacture Sphingomab™, Lpath’s lipid-specific humanized Mab. Laureate will provide the full-scale development of this product for clinical trials, including cell-line development, optimization, upstream and downstream development, and final cGMP manufacture. “We strive to combine biomanufacturing expertise with flexibility ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.